1-6 of 6
Authors: Liangfu Zhou
Journal Article
CTIM-07. PHASE IIB RANDOMIZED, BLINDED, CONTROLLED TRIAL EVALUATING NEOADJUVANT PD-1 BLOCKADE COMBINED WITH A2B5+ GLIOMA STEM-LIKE CELL LYSATE-LOADED DCV IN RECURRENT GLIOBLASTOMA (IDH1/2 -)- TRAIL IN PROGRESS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v62, https://doi.org/10.1093/neuonc/noad179.0247
Published: 10 November 2023
Journal Article
TMIC-11. ENHANCED B7-H4 EXPRESSION IN GLIOMAS WITH LOW PD-L1 EXPRESSION IDENTIFIES COLD TUMORS Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi249, https://doi.org/10.1093/neuonc/noz175.1045
Published: 11 November 2019
Journal Article
Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas Free
Neuro-Oncology, Volume 19, Issue 7, July 2017, Pages 1008–1010, https://doi.org/10.1093/neuonc/nox042
Published: 15 June 2017
Journal Article
Adult IDH wild-type lower-grade gliomas should be further stratified Free
Neuro-Oncology, Volume 19, Issue 10, October 2017, Pages 1327–1337, https://doi.org/10.1093/neuonc/nox078
Published: 27 May 2017
Journal Article
MPTH-24COMBINATION GENETIC SIGNATURE STRATIFIES PROGNOSIS IN LOWER-GRADE GLIOMAS BUT IDH STATUS ALONE DOES NOT SUPERSEDE HISTOLOGIC GRADES Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v143, https://doi.org/10.1093/neuonc/nov222.24
Published: 09 November 2015
Journal Article
MB-04EXPRESSION OF CRMP1 INHIBITS CELL PROLIFERATION OF MEDULLOBLASTOMA AND IS REGULATED BY HMGA1 Get access
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Page iii20, https://doi.org/10.1093/neuonc/nov061.80
Published: 21 April 2015
